Clinical Trials Browser

Prostatic Neoplasms × Androgen Receptor Antagonists × 90 days × Clear all

NCT04946370 2026-04-21

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Recruiting

Prostatic Neoplasms